Table 1 Socio-demographic characteristics of the study population
Overall | Treatment non-adherence based on Morisky-Green baseline score | ||||
|---|---|---|---|---|---|
High-Risk | Low-Risk | p-value | |||
N = 114 | 27 (23.7) | 87 (76.3) | |||
Gender | |||||
Men | n(%) | 93 (81.6) | 18 (66.7) | 75 (86.2) | 0.043F |
Women | n(%) | 21 (18.4) | 9 (33.3) | 12 (13.8) | |
Missing | n | 0 | 0 | 0 | |
Age (years) | |||||
Mean (S.D.) | 69.6 (9.1) | 68.3 (10.0) | 70.0 (8.8) | 0.449U | |
≤ 65 years | n(%) | 44 (38.6) | 11 (40.7) | 33 (37.9) | 0.793C |
> 65 years | n(%) | 70 (61.4) | 16 (59.3) | 54 (62.1) | |
Missing | n | 0 | 0 | 0 | |
Level of education | |||||
No studies/Primary studies | n(%) | 78 (68.4) | 17 (63.0) | 61 (70.1) | 0.485C |
Intermediate and higher education | n(%) | 36 (31.6) | 10 (37.0) | 26 (29.9) | |
Missing | n | 0 | 0 | 0 | |
Employment situation | |||||
Retired | n(%) | 80 (70.2) | 16 (59.3) | 64 (73.6) | 0.156C |
Other | n(%) | 34 (29.8) | 11 (40.7) | 23 (26.4) | |
Missing | n | 0 | 0 | 0 | |
BMI (kg/m2) | |||||
Mean (S.D.) | 27.8 (5.5) | 27.8 (6.2) | 27.8 (5.3) | 0.931U | |
Underweight (<18.5) | n(%) | 3 (2.6) | 1 (3.7) | 2 (2.3) | 0.738F |
Normal weight (18.5–24.9) | n(%) | 36 (31.6) | 10 (37.0) | 26 (29.9) | |
Overweight (25.0–29.9) | n(%) | 41 (36.0) | 8 (29.6) | 33 (37.9) | |
Obesity (≥30.0) | n(%) | 34 (29.8) | 8 (29.6) | 26 (29.9) | |
Missing | n | 0 | 0 | 0 | |
Cardiovascular risk | |||||
None | n(%) | 31 (27.2) | 8 (29.6) | 23 (26.4) | 0.907C |
Increased | n(%) | 27 (23.7) | 5 (18.5) | 22 (25.3) | |
High | n(%) | 29 (25.4) | 7 (25.9) | 22 (25.3) | |
Very/Extremely high | n(%) | 27 (23.7) | 7 (25.9) | 20 (23.0) | |
Missing | n | 0 | 0 | 0 | |
Smoking status | |||||
Ex-smoker | n(%) | 91 (79.8) | 17 (63.0) | 74 (86.1) | 0.012C |
Smoker | n(%) | 23 (20.2) | 10 (37.0) | 13 (14.9) | |
Missing | n | 0 | 0 | 0 | |
COPD treatment (at baseline) | n(%) | 112 (98.2) | 27 (100.0) | 85 (97.7) | 1.000C |
Long-acting B2 agonists | n(%) | 101 (90.2) | 23 (85.2) | 78 (91.8) | 0.456F |
Long-acting anticholinergics | n(%) | 99 (88.4) | 24 (88.9) | 75 (88.2) | 1.000F |
Phosphodiesterase-4 Inhibitors | n(%) | 30 (26.8) | 6 (22.2) | 24 (28.2) | 0.539C |
Inhaled Corticosteroids | n(%) | 88 (78.6) | 17 (63.0) | 71 (83.5) | 0.023C |
Oxygen therapy | n(%) | 32 (28.6) | 4 (14.8) | 28 (32.9) | 0.069C |
non-invasive mechanical ventilation | n(%) | 12 (10.7) | 4 (14.8) | 8 (9.4) | 0.479F |
Missing | n | 0 | 0 | 0 | |